<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08033661807345</udiDi>
    <basicUdiDi>B-08033661807345</basicUdiDi>
    <tradeName>HY-TISSUE MICROGRAFT TECHNOLOGY</tradeName>
    <deviceName>HY-TISSUE MICROGRAFT TECHNOLOGY</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>V9099</emdnCode>
    <emdnDescription>VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10000663</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T09:16:39.578Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033661804672</udiDi>
    <basicUdiDi>B-08033661804672</basicUdiDi>
    <tradeName>HY-TISSUE MICROGRAFT TECHNOLOGY</tradeName>
    <deviceName>HY-TISSUE MICROGRAFT TECHNOLOGY</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>V9099</emdnCode>
    <emdnDescription>VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10000664</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-07T09:16:35.584Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-04DM4138NP</udiDi>
    <basicUdiDi>B-04DM4138NP</basicUdiDi>
    <tradeName>GASA ESTÉRIL</tradeName>
    <deviceName>GASA ESTÉRIL</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>M0201020101</emdnCode>
    <emdnDescription>COTTON GAUZES, FOLDED, WITHOUT X-RAY DETECTABLE THREAD, STERILE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04DM4138</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-06T05:14:32.280Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267242924</udiDi>
    <basicUdiDi>80336618006060100000000VV</basicUdiDi>
    <tradeName>RYM NASAL GEL</tradeName>
    <deviceName>RYM NASAL GEL</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q030199</emdnCode>
    <emdnDescription>NASOPHARYNGEAL DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001209</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:16:13.998Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267242887</udiDi>
    <basicUdiDi>80336618006030100000000SY</basicUdiDi>
    <tradeName>HIDRAFEM</tradeName>
    <deviceName>HIDRAFEM</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0899</emdnCode>
    <emdnDescription>GYNAECOLOGICAL DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001813</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:16:13.195Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241576</udiDi>
    <basicUdiDi>80336618004030100000000QE</basicUdiDi>
    <tradeName>BLUYAL</tradeName>
    <deviceName>BLUYAL</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001264</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:16:12.454Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241545</udiDi>
    <basicUdiDi>80336618004210200000000RH</basicUdiDi>
    <tradeName>TRIUM MONODOSE</tradeName>
    <deviceName>TRIUM MONODOSE</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001268</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:16:11.593Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241057</udiDi>
    <basicUdiDi>80336618005020100000000QQ</basicUdiDi>
    <tradeName>HY-TISSUE PRP 20</tradeName>
    <deviceName>HY-TISSUE PRP 20</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>B06</emdnCode>
    <emdnDescription>CELLULAR OR BIOLOGICAL MANIPULATION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001196</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:16:07.595Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267240869</udiDi>
    <basicUdiDi>80336618005030100000000RP</basicUdiDi>
    <tradeName>DUOGRAFTER II</tradeName>
    <deviceName>DUOGRAFTER II</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9099</emdnCode>
    <emdnDescription>VARIOUS DEVICES NOT INCLUDED IN OTHER CLASSES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001194</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:16:06.789Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033661809509</udiDi>
    <basicUdiDi>80336618004210100000000QS</basicUdiDi>
    <tradeName>TRIUM</tradeName>
    <deviceName>TRIUM</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10001215</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:08:54.961Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033661809431</udiDi>
    <basicUdiDi>80336618004170100000000VF</basicUdiDi>
    <tradeName>RESPILAC</tradeName>
    <deviceName>RESPILAC</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10001212</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:08:54.149Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033661809424</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>FIDIALEYE NORM</tradeName>
    <deviceName>EDENORM</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10001211</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:08:50.121Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033661809592</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>FIDIALEYE NORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11000361</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:04:08.361Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033661809608</udiDi>
    <basicUdiDi>80336618004170100000000VF</basicUdiDi>
    <tradeName>RESPILAC</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11000362</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:04:08.342Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033661809639</udiDi>
    <basicUdiDi>80336618004210100000000QS</basicUdiDi>
    <tradeName>TRIUM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030206</emdnCode>
    <emdnDescription>EYE LUBRICANT SOLUTIONS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11000365</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:04:08.313Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241439</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>EDENORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001250</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.415Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241453</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>EDENORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001256</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.399Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241477</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>FIDIALEYE NORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001254</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.388Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241484</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>FIDIALEYE NORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001257</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.376Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055267241491</udiDi>
    <basicUdiDi>80336618004060100000000TB</basicUdiDi>
    <tradeName>FIDIALEYE NORM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001258</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:08:09.360Z</lastUpdated>
  </row>
</eudamedExport>